Strategic Access Healthagen leverages deep access to Aetna data, affiliated institutions, and extensive provider networks, presenting a compelling opportunity to offer expanded real-world evidence services, payer-driven analytics, and population health strategies to CVS Health and partner entities.

Data Scale The ability to utilize longitudinal claims data from up to 23 million Aetna members positions Healthagen to support large-scale health economics outcomes research, value-based contracting insights, and market access analyses that can be sold to pharmaceutical, biotech, and device companies.

Value Based With 800+ value-based contracts and 77 ACO partnerships, there is a clear pathway to cross-sell advanced analytics, adherence monitoring, and real-world evidence programs to clients seeking to demonstrate economic value and outcomes in real clinical settings.

Acquisition Opportunity Given its acquisition by Aetna in 2023 and its positioning within the CVS Health ecosystem, Healthagen can be bundled with CVS Aetna offerings to provide end-to-end analytics, commercialization support, and integrated population health solutions to current and prospective customers.

Tech & Engagement Current tech stack and marketing automation tools suggest readiness for enhanced digital engagement and scalable analytics delivery; sales opportunities exist to upsell modernization services, data visualization, and integrated reporting for pharma and healthcare clients.